tiprankstipranks
Trending News
More News >
Appili Therapeutics Inc Class A (APLIF)
:APLIF
US Market
Advertisement

Appili Therapeutics Inc Class A (APLIF) Financial Statements

Compare
82 Followers

Appili Therapeutics Inc Class A Financial Overview

Appili Therapeutics Inc Class A's market cap is currently $1.32M. The company's EPS TTM is $0.001455874; its P/E ratio is ―; Appili Therapeutics Inc Class A is scheduled to report earnings on June 25, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total RevenueC$ 100.44KC$ 827.41KC$ 334.18KC$ 1.39MC$ 0.00
Gross ProfitC$ 100.44KC$ 827.41KC$ 327.91KC$ 1.39MC$ -14.84K
Operating IncomeC$ -190.84KC$ -2.16MC$ -7.91MC$ -24.68MC$ -16.30M
EBITDAC$ 360.57KC$ -2.10MC$ -8.19MC$ -24.31MC$ -14.87M
Net IncomeC$ -2.62MC$ -3.78MC$ -9.24MC$ -25.12MC$ -14.33M
Balance Sheet
Cash & Short-Term InvestmentsC$ 1.23MC$ 94.49KC$ 2.47MC$ 6.66MC$ 16.12M
Total AssetsC$ 3.03MC$ 1.49MC$ 3.13MC$ 8.28MC$ 18.32M
Total DebtC$ 12.29MC$ 8.18MC$ 7.67MC$ 4.98MC$ 1.03M
Net DebtC$ 11.07MC$ 8.09MC$ 5.20MC$ -1.69MC$ -10.03M
Total LiabilitiesC$ 16.43MC$ 12.42MC$ 10.53MC$ 11.55MC$ 5.56M
Stockholders' EquityC$ -13.40MC$ -10.92MC$ -7.40MC$ -3.27MC$ 12.75M
Cash Flow
Free Cash FlowC$ 866.46KC$ -2.49MC$ -10.10MC$ -19.08MC$ -11.46M
Operating Cash FlowC$ 868.82KC$ -2.46MC$ -10.10MC$ -19.08MC$ -11.45M
Investing Cash FlowC$ -2.36KC$ -29.06KC$ -3.17KC$ 5.06MC$ -4.99M
Financing Cash FlowC$ 193.68KC$ 122.05KC$ 5.91MC$ 9.56MC$ 17.02M
Currency in CAD

Appili Therapeutics Inc Class A Earnings and Revenue History

Appili Therapeutics Inc Class A Debt to Assets

Appili Therapeutics Inc Class A Cash Flow

Appili Therapeutics Inc Class A Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis